> top > docs > PubMed:28390726 > annotations

PubMed:28390726 JSONTXT

Annnotations TAB JSON ListView MergeView

GoldHamster

Id Subject Object Predicate Lexical cue
T1 22-30 CHEBI:33284 denotes nutrient
T2 76-82 UBERON:0000479 denotes tissue
T3 98-111 UBERON:0001911 denotes mammary gland
T4 98-111 UBERON:0005200 denotes mammary gland
T6 251-264 UBERON:0001911 denotes mammary gland
T7 251-264 UBERON:0005200 denotes mammary gland
T9 288-296 CHEBI:33284 denotes nutrient
T10 377-385 CHEBI:33284 denotes nutrient
T11 407-420 UBERON:0001911 denotes mammary gland
T12 407-420 UBERON:0005200 denotes mammary gland
T13 407-432 GO:0030879 denotes mammary gland development
T16 466-479 UBERON:2000098 denotes proliferation
T17 575-579 UBERON:0001913 denotes milk
T23 721-728 SO:0000104 denotes protein
T22 721-728 PR:000000001 denotes protein
T19 721-728 GO:0003675 denotes protein
T20 721-728 CHEBI:36080 denotes protein
T21 721-728 CHEBI:11122 denotes protein
T24 734-737 UBERON:0001013 denotes fat
T25 734-737 CHEBI:24021 denotes fat
T26 738-742 UBERON:0001913 denotes milk
T29 917-928 D001835 denotes body weight
T30 917-928 D001835 denotes body weight
T34 1048-1055 PR:000000001 denotes protein
T32 1048-1055 CHEBI:36080 denotes protein
T33 1048-1055 CHEBI:11122 denotes protein
T35 1048-1055 SO:0000104 denotes protein
T31 1048-1055 GO:0003675 denotes protein
T36 1067-1071 UBERON:0003823 denotes calf
T38 1177-1181 UBERON:0003823 denotes calf
T39 1194-1198 UBERON:0003823 denotes calf
T48 1277-1281 UBERON:0003823 denotes calf
T49 1294-1298 UBERON:0003823 denotes calf
T50 1351-1360 CL:0000034 denotes stem cell
T51 1351-1374 GO:0072089 denotes stem cell proliferation
T53 1361-1374 UBERON:2000098 denotes proliferation
T54 1376-1380 CHEBI:472552 denotes BrdU
T55 1376-1380 D001973 denotes BrdU
T56 1376-1380 D001973 denotes BrdU
T57 1382-1405 CHEBI:472552 denotes 5-bromo-2'-deoxyuridine
T58 1382-1405 D001973 denotes 5-bromo-2'-deoxyuridine
T59 1382-1405 D001973 denotes 5-bromo-2'-deoxyuridine
T66 1546-1557 D001835 denotes body weight
T67 1546-1557 D001835 denotes body weight
T68 1674-1679 UBERON:0002107 denotes liver
T69 1690-1698 UBERON:3011040 denotes pancreas
T70 1690-1698 UBERON:0001264 denotes pancreas
T71 1714-1727 UBERON:0001911 denotes mammary gland
T72 1714-1727 UBERON:0005200 denotes mammary gland
T74 1741-1751 UBERON:0000353 denotes parenchyma
T75 1791-1796 UBERON:0000062 denotes organ
T76 1791-1796 UBERON:0003103 denotes organ
T77 1878-1883 UBERON:0000062 denotes organ
T78 1878-1883 UBERON:0003103 denotes organ
T79 1910-1921 D001835 denotes body weight
T80 1910-1921 D001835 denotes body weight
T81 2078-2083 CVCL_C076 denotes had 5
T82 2141-2154 UBERON:0001911 denotes mammary gland
T83 2141-2154 UBERON:0005200 denotes mammary gland
T85 2173-2181 CHEBI:33284 denotes nutrient
T86 2230-2243 UBERON:0001911 denotes mammary gland
T87 2230-2243 UBERON:0005200 denotes mammary gland
T89 2367-2371 CHEBI:472552 denotes BrdU
T90 2367-2371 D001973 denotes BrdU
T91 2367-2371 D001973 denotes BrdU
T92 2372-2377 CHEBI:35209 denotes label
T93 2424-2430 UBERON:0000479 denotes tissue
T94 2560-2565 CHEBI:35209 denotes label
T95 2733-2746 UBERON:0001911 denotes mammary gland
T96 2733-2746 UBERON:0005200 denotes mammary gland

PubMed_ArguminSci

Id Subject Object Predicate Lexical cue
T1 84-210 DRI_Background denotes Historically, mammary gland growth has been considered isometric the first 2 mo of life and then allometric until peripuberty.
T2 211-315 DRI_Background denotes However, recent work indicated that the mammary gland might be responsive to nutrient intake preweaning.
T3 316-513 DRI_Background denotes The objectives of this study were to describe the effects of nutrient intake preweaning on mammary gland development and to investigate cell specific proliferation during this phase of development.
T4 514-663 DRI_Approach denotes Twelve dairy heifer calves were fed either a fixed amount of milk replacer (MR; control, n = 6) or an amount of MR adjusted for BW (enhanced, n = 6).
T5 664-991 DRI_Outcome denotes Control calves received a constant amount of a 28% crude protein, 15% fat milk MR per day that was equivalent to 2.8 Mcal of metabolizable energy intake per day; enhanced calves received 0.3 Mcal of metabolizable energy intake per kilogram of metabolic body weight (from 4.2 to 8.4 Mcal of metabolizable energy intake per day).
T6 992-1080 DRI_Approach denotes All calves had constant access to water and a 22% crude protein commercial calf starter.
T7 1081-1320 DRI_Outcome denotes Calves were killed at 54 ± 2 d. Control calves consumed 32.6 ± 2.4 kg of MR and 6.7 ± 0.5 kg of calf starter per calf, whereas the enhanced calves consumed 69.5 ± 2.4 kg of MR and 1.9 ± 0.5 kg of calf starter per calf over the 54-d period.
T8 1321-1527 DRI_Approach denotes Further, to evaluate putative stem cell proliferation, BrdU (5-bromo-2'-deoxyuridine; 5 mg/kg) was injected intramuscularly once per day between 12 to 15 d and again once per day between 24 to 27 d of life.
T9 1528-1647 DRI_Background denotes Initial and final body weight for the control and enhanced treatments were 39.2, 61.0, 39.7, and 83.2 kg, respectively.
T10 1648-1766 DRI_Background denotes At euthanasia, weights of liver, kidneys, pancreas, whole skinned mammary gland, and mammary parenchyma were measured.
T11 1767-1922 DRI_Outcome denotes The growth rate of each organ was calculated using the concept of allometry as the difference in the change in organ weight as a percentage of body weight.
T12 1923-2204 DRI_Background denotes The mammary glands of calves fed the enhanced diet were significantly heavier at euthanasia; when mammary parenchymal weight was analyzed, enhanced calves had 5.9 times greater mammary parenchymal mass, indicating the mammary gland was responsive to nutrient intake before weaning.
T13 2205-2310 DRI_Approach denotes Allometric growth of the mammary gland was initiated preweaning in the calves fed the enhanced treatment.
T14 2311-2747 DRI_Approach denotes Further characterization of mammary cells that retained BrdU label revealed no significant differences among the tissue slices analyzed between treatments; however, as calves fed the enhanced diet had more mammary parenchymal mass, if the number of label-retaining cells per counted slide were similar between treatments then the enhanced calves had a larger total population of putative mammary stem cells present in the mammary gland.

Goldhamster2_Cellosaurus

Id Subject Object Predicate Lexical cue
T1 119-122 CVCL_6758|Undefined_cell_line_type|Cricetulus griseus denotes has
T2 119-122 CVCL_E689|Transformed_cell_line|Homo sapiens denotes has
T3 161-163 CVCL_1439|Cancer_cell_line|Homo sapiens denotes mo
T4 161-163 CVCL_7019|Cancer_cell_line|Homo sapiens denotes mo
T5 557-558 CVCL_6479|Finite_cell_line|Mus musculus denotes a
T6 603-608 CVCL_D461|Transformed_cell_line|Mus musculus denotes n = 6
T7 613-615 CVCL_8754|Cancer_cell_line|Homo sapiens denotes an
T8 613-615 CVCL_H241|Cancer_cell_line|Homo sapiens denotes an
T9 656-661 CVCL_D461|Transformed_cell_line|Mus musculus denotes n = 6
T10 688-689 CVCL_6479|Finite_cell_line|Mus musculus denotes a
T11 709-710 CVCL_6479|Finite_cell_line|Mus musculus denotes a
T12 1036-1037 CVCL_6479|Finite_cell_line|Mus musculus denotes a
T13 1038-1040 CVCL_WT45|Hybridoma|Mus musculus denotes 22
T14 1103-1105 CVCL_ZT26|Transformed_cell_line|Homo sapiens denotes 54
T15 1308-1310 CVCL_ZT26|Transformed_cell_line|Homo sapiens denotes 54
T16 1514-1516 CVCL_T366|Transformed_cell_line|Chlorocebus aethiops denotes 27
T17 1868-1874 CVCL_0238|Cancer_cell_line|Homo sapiens denotes change
T18 1894-1895 CVCL_6479|Finite_cell_line|Mus musculus denotes a
T19 2082-2085 CVCL_J991|Hybridoma|Mus musculus denotes 5.9
T20 2086-2091 CVCL_0047|Telomerase_immortalized_cell_line|Homo sapiens denotes times
T21 2372-2377 CVCL_3734|Finite_cell_line|Homo sapiens denotes label
T22 2560-2565 CVCL_3734|Finite_cell_line|Homo sapiens denotes label
T23 2661-2662 CVCL_6479|Finite_cell_line|Mus musculus denotes a